Control of the spread of vancomycin-resistant enterococci in hospitals: Epidemiology and clinical relevance

Deutsches Arzteblatt International

Volumn 110, Issue 43, 2013, Pages

  Mutters, Nico T ^a   Mersch Sundermann, Volker ^a   Mutters, Reinier ^a   Brandt, Christian ^a   Schneider Brachert, Wulf ^a   Frank, Uwe ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BACTERIAL COLONIZATION; DIARRHEA; ENTEROCOCCUS FAECIUM; HOSPITAL HYGIENE; HOSPITAL INFECTION; INFECTION CONTROL; INFECTION RISK; INTUBATION; MICROBIOLOGICAL EXAMINATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; WARD;

CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; GERMANY; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; HYGIENE; INCIDENCE; PATIENT ISOLATION; PREVALENCE; RISK FACTORS; SURVIVAL RATE; VANCOMYCIN;

EID: 84888584593     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0725     Document Type: Article

References (56)

1. Bradley CR, Fraise AP: Heat and chemical resistance of enterococci. J Hosp Infect 1996; 34: 191-6.
2. Arias CA, Murray BE: The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012; 10: 266-78.
3. Leavis HL, Willems RJ, Mascini EM, Vandenbroucke-Grauls CM, Bonten MJ: (Vancomycin resistant enterococci in the Netherlands). Ned Tijdschr Geneeskd 2004; 148: 878-82.
4. Klare I, Witte W, Wendt C, Werner G: (Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2012; 55: 1387-400.
5. Stinear TP, Olden DC, Johnson PD, Davies JK, Grayson ML: Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet 2001; 357: 855-6.
6. Murray BE: The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
7. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, et al.: Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76-9.
8. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, et al.: Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008; 13: 1-11.
9. Mutters NT, Frank U: Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci. Infection 2013; 41: 305-10.
10. Epidemiologie und Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem Hospitalbereich gegenüber Antibiotika (database on the Internet)1998-2010. www.p-e-g.org/ag-resistenz/main.htm. Last accessed: Oct 2012
11. Mattner F, Bange FC, Meyer E, Seifert H, Wichelhaus TA, Chaberny IF: Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society of Hygiene and Microbiology. Dtsch Arztebl Int 2012; 108(3): 39-45.
12. EARSS-Net Database (database on the Internet). ECDC. 1998-2010. /www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/database.aspx. Last accessed: Oct 2012
13. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P: Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 2010; 14: R113.
14. Kohlenberg A, Schwab F, Meyer E, Behnke M, Geffers C, Gastmeier P: Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis. J Hosp Infect 2009; 73: 239-45.
15. Griffin PM, Price GR, Schooneveldt JM, Schlebusch S, Tilse MH, Urbanski T, et al.: Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak. J Clin Microbiol 2012; 50: 2918-31.
16. Willems RJ, van Schaik W: Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol 2009; 4: 1125-35.
17. Lee WG, Park IJ, Jin HY, Park MH: Relapse and reacquisition of rectal colonization by vancomycin-resistant Enterococcus faecium after decolonization. Epidemiol Infect 2010; 138: 1449-53.
18. Park I, Park RW, Lim SK, Lee W, Shin JS, Yu S, et al.: Rectal culture screening for vancomycin-resistant enterococcus in chronic haemodialysis patients: false-negative rates and duration of colonisation. J Hosp Infect 2011; 79: 147-50.
19. Mutters NT, Brooke RJ, Frank U, Heeg K: Low risk of apparent transmission of vancomycin-resistant Enterococci from bacteraemic patients to hospitalized contacts. Am J Infect Control 2013; pii: S0196-6553(13)00060-6 [Epub ahead of print]
20. Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, et al.: Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect 2013; 19: E181-9.
21. DiazGranados CA, Jernigan JA: Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191: 588-95.
22. Worth LJ, Thursky KA, Seymour JF, Slavin MA. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007; 79: 226-33.
23. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41: 327-33.
24. McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, et al.: Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006; 42: 195-203.
25. Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM, Busuttil RW et al.: Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant. 2008; 8: 1737-43.
26. Lee WG, Ahn SH, Jung MK, Jin HY, Park IJ: Characterization of a vancomycin-resistant Enterococcus faecium outbreak caused by 2 genetically different clones at a neonatal intensive care unit. Ann Lab Med 2012; 32: 82-6.
27. Se YB, Chun HJ, Yi HJ, Kim DW, Ko Y, Oh SJ: Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients. J Korean Neurosurg Soc 2009; 46: 123-9.
28. Tacconelli E, Karchmer AW, Yokoe D, D'Agata EM: Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. Clin Infect Dis 2004; 39: 964-70.
29. Askarian M, Afkhamzadeh R, Monabbati A, Daxboeck F, Assadian O: Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran. Int J Infect Dis 2008; 12: 171-5.
30. Kee SY, Park CW, Lee JE, Kwon YJ, Pyo HJ, Kim WJ, et al.: Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis. Jpn J Infect Dis 2012; 65: 57-60.
31. Haas EJ, Zaoutis TE, Prasad P, Li M, Coffin SE: Risk Factors and Outcomes for Vancomycin-Resistant Enterococcus Bloodstream Infection in Children. Infect Control Hosp Epidemiol 2010; 31: 1038-42.
32. Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, Heo JY, et al.: Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control 2009; 37: 734-40.
33. Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG: Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 2000; 21: 575-82.
34. Forrest GN, Arnold RS, Gammie JS, Gilliam BL: Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect 2011; 63: 420-8.
35. Polidori M, Nuccorini A, Tascini C, Gemignani G, Iapoce R, Leonildi A, et al.: Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline. J Chemother 2011; 23: 240-1.
36. Theilacker C, Jonas D, Huebner J, Bertz H, Kern WV: Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak. Infection 2009; 37: 540-3.
37. Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA: Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006; 42: 1552-60.
38. Hachem R, Graviss L, Hanna H, Arbuckle R, Dvorak T, Hackett B, et al.: Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 2004; 25: 391-4.
39. Sample ML, Gravel D, Oxley C, Toye B, Garber G, Ramotar K: An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol 2002; 23: 468-70.
40. Kaier K, Mutters NT, Frank U: Bed occupancy rates and hospital-acquired infections-should beds be kept empty? Clin Microbiol Infect 2012; 18: 941-5.
41. Lee S.C., Wu M.S., Shih H.J., Huang S.H., Chiou M.J., See L.C., et al.: Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan. BMC Infect Dis 2013; 13: 163.
42. Vonberg RP, Chaberny IF, Kola A, Mattner F, Borgmann S, Dettenkofer M et al.: [Prevention and control of the spread of vancomycin-resistant enterococci: results of a workshop held by the German Society for Hygiene and Microbiology]. Anaesthesist 2007; 56: 151-7.
43. von Baum H, Dettenkofer M, Fahr AM, Heeg P, Wendt C: Konsensusempfehlung Baden-Württemberg: Umgang mit Glykopeptidresistenten Enterokokken (GRE) / Vancomycin-resistenten Enterokokken (VRE). Hyg Med 2006; 1/2: 30-3.
44. Robert-Koch-Institut: Vancomycin-resistente Enterokokken in deutschen Krankenhäusern 2006/2007. Epidemiologisches Bulletin 2008; 23: 179-89.
45. Robert-Koch-Institut: Zum Aufwand von MRSA-Screening-untersuchungen in deutschen Krankenhäusern. Epidemiologisches Bulletin 2013: 41-8.
46. Nolan SM, Gerber JS, Zaoutis T, Prasad P, Rettig S, Gross K, et al.: Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients. Infect Control Hosp Epidemiol 2009; 30: 338-45.
47. Aumeran C, Baud O, Lesens O, Delmas J, Souweine B, Traore O: Successful control of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in France. Eur J Clin Microbiol Infect Dis 2008; 27: 1061-4.
48. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM: Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003; 37: 326-32.
49. Morris-Downes M, Smyth EG, Moore J, Thomas T, Fitzpatrick F, Walsh J, et al.: Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible. J Hosp Infect 2010; 75: 228-33.
50. Price CS, Paule S, Noskin GA, Peterson LR: Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003; 37: 921-8.
51. Ostrowsky BE, Trick WE, Sohn AH, Quirk SB, Holt S, Carson LA, et al.: Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344: 1427-33.
52. Sherer CR, Sprague BM, Campos JM, Nambiar S, Temple R, Short B, et al.: Characterizing vancomycin-resistant enterococci in neonatal intensive care. Emerg Infect Dis 2005; 11: 1470-2.
53. Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A; et al.: Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill 2012; 17: 1-7.
54. Jones D: How to reduce the negative psychological impact of MRSA isolation on patients. Nurs Times 2010; 106: 14-6.
55. Mackenzie D, Edwards A: MRSA: the psychological effects. Nurs Stand 1997; 12: 49-53; quiz 5-6.
56. Mozzillo KL, Ortiz N, Miller LG: Patients with methicillin-resistant Staphylococcus aureus infection: twenty-first century lepers. J Hosp Infect 2010; 75: 132-4.